Patents (1436 Stem Cell Patents)

Class: Use (276)

Order by:
<< | < | 24 25 26 27 28


Method for the treatment of grafts prior to transplantation using TGF-.beta .

Patent Number: 5135915

This is a patent covering the de-immunization of an organ by treatment with TGF-b before transplantation. The organs that may be used include heart, liver, spleen, pancreas, thyroid lobe, lung, kidney, intestine, blood vessel, and esophagus. The use of TGF bet to decrease immunogenecity is supported by other observations that this...

Inventors: Czarniecki, Christine W. (San Francisco, CA); Palladino, Michael A. (Foster City, CA); Shefter, Eli (San Francisco, CA)
Assignee: Genentech, Inc. (South San Francisco, CA)
Date of First Priority Issue: Friday October 14th, 1988

Method of regenerating or replacing cartilage tissue using amniotic cells

Patent Number: 5612028

This patent teaches the use of stem cells derived from amniotic tissue for regeneration of cartilage tissue. The stem cells of the amniotic tissue claimed are epithelial and free of mesenchymal tissue.

Inventors: Sackier, Jonathan M. (Surrey, GB3); Wood, Christopher B. (Buckinghamshire, GB3); Krishnan, Rajagopallan (Surrey, GB3); Wiggington, Gordon R. (Hampshire, GB3); Butler, Douglas Mitchel H. (Surrey, GB3)
Assignee: Genethics Limited (Surrey, GB)
Date of First Priority Issue: Wednesday February 17th, 1988

Gene transfer using transformed, neodetermined, embryonic cells

Patent Number: 5032407

This patent teaches that embryonic yolk sac, midbrain, and forbrain cells may be gene transfected with a useful gene and utilized as a vector for delivery of the gene to an area of need.

Inventors: Wagner, Thomas E. (Athens, OH); Reed, Michael A. (Athens, OH); Corn, Barbara J. (Athens, OH)
Assignee: Ohio University Edison Animal Biotechnology Center (Athens, OH)
Date of First Priority Issue: Friday January 16th, 1987

Method for recombinant production of human pluripotent granulocyte colony-stimulating factor

Patent Number: 5830705

This is a patent on ways of generating a cytokine called human p-G-CSF. I wonder what the modern name of this cytokine is? In any case, the invention teaches that this cytokine stimulates hematopoietic stem cells proliferation.

Inventor: Souza, Lawrence M. (Witherspoon, CA)
Assignee: Amgen Inc. (Thousand Oaks, CA)
Date of First Priority Issue: Friday August 23rd, 1985

Methods of enhancing bone marrow transplantation and treating burn wounds comprising administering human pluripotent granulocyte colony-stimulating factor

Patent Number: 5676941

Like other hematopoietic cytokines, this patent teaches that hpG-CSF may be administered for the treatment of burn wounds.

Inventor: Souza, Lawrence M. (Thousand Oaks, CA)
Assignee: Amgen Inc. (Thousand Oaks, CA)
Date of First Priority Issue: Friday August 23rd, 1985

Methods of treating bacterial inflammation and granulocytopoiesis by administering human pluripotent granulocyte colony-stimulating factor

Patent Number: 5582823

This patent covers the use of human pluripotent granulocyte colony stimulating factor for induction of granulocyte production, as well as for reducing bacterially mediated inflammation. The use of growth factors such as the one described has expanded in recent years to other types of stem cells besides hematopoietic stem cells. It will be interesting to see first what the new name for the...

Inventor: Souza, Lawrence M. (Thousand Oaks, CA)
Assignee: Amgen Inc. (Thousand Oaks, CA)
Date of First Priority Issue: Friday August 23rd, 1985

Order by:
<< | < | 24 25 26 27 28

Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2024 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.04

Stouffville Concrete | Tottenham Concrete | Uxbridge Concrete | Gerogetown Concrete | Rockwood Concrete | Kleinburg Concrete | Breslau Concrete | Stouffville Real Estate Agent